Latest / The Acquisition Talk with Fexingo: Mergers, Buyouts, and Business Sales for Operators / Why Earnouts Are the New Debt Trap for Sellers
Transcript
- Lucas: If you have been watching the M&A landscape closely over the last eighteen months, you will notice a distinct shift in how buyers are bridging valuation gaps. We used to see cash-heavy offers or clear multiples of earnings, but now, nearly half of all mid-market healthcare technology deals include some form of deferred consideration tied to future performance. Luna: That is a significant swing from the transactional simplicity we saw during the peak liquidity years. Why do sellers agree to this kind of uncertainty when they could just walk away? Lucas: Because the alternative is no deal at all. When interest rates are elevated and capital costs are high, buyers are reluctant to pay full price upfront. They want to defer payment until they can verify that the growth projections actually materialize, effectively making the seller finance their own acquisition. Luna: So the seller becomes the lender? That sounds like a recipe for misaligned incentives once the closing papers are signed. Lucas: Exactly. And this is where the real danger lies for founders. The buyer controls the integration, the sales force, and often the definition of the metrics themselves. If the target was two million dollars in recurring revenue, but the buyer decides to rebrand the product line or shift the sales channel, the seller might never hit that number. Luna: It feels less like an equity roll-over and more like a loan with very aggressive covenants. Has there been a specific case recently that illustrates this dynamic? Lucas: There was a notable transaction involving a mid-sized patient data analytics firm that closed earlier this year. The purchase price was split thirty percent upfront and seventy percent over three years based on net revenue retention. It looked generous on paper until the buyer integrated the platform into their legacy suite. Luna: Did the buyer change the pricing model or just bury the product inside a larger package? Lucas: They did both. By bundling the analytics tool with a broader electronic health records offering, they diluted the standalone revenue visibility. The contract specified gross revenue from the specific module, but the accounting treatment changed during integration, making it nearly impossible for the seller to prove they were meeting the threshold. Luna: That is brutal. You sold the company, but you lost control of the financial narrative that determines your payout. Lucas: Precisely. And the worst part is that these clauses are rarely litigated because the legal fees would dwarf the remaining earnout payments. Most sellers just absorb the loss and hope for better terms next time. Luna: It makes me wonder if there is a middle ground where the metrics are auditable without giving the buyer total discretion over the reporting. Lucas: That is what I want to explore today. We are going to dissect the structural protections that savvy operators can demand before signing an earnout agreement. We need to move past the handshake deals of the past and focus on the specific contractual levers that prevent this kind of value erosion. Luna: I am curious about the role of independent audits in these contracts. Do sellers ever get a say in who verifies the numbers? Lucas: Absolutely, though it is often treated as a minor administrative detail rather than a core protection. Let us start by looking at the baseline definitions. What exactly counts as revenue under the earnout clause? Luna: Most people assume it is straightforward top-line growth, but I suspect the accounting adjustments make it much messier. Lucas: You are right. In many recent deals, we have seen buyers deduct not only direct costs but also allocated overhead from corporate headquarters. Suddenly, the revenue target is moving goalposts because the seller is being charged for rent, HR, and legal support they did not previously manage. Luna: That essentially transfers fixed operational costs onto the variable performance metric. It feels like a tax on success. Lucas: It is a clever way to reduce the payout while maintaining the appearance of fairness. To combat this, forward-thinking sellers are now insisting on capped overhead allocations or fully distributed cost structures that mirror the pre-acquisition operating model. Luna: Do you think this level of scrutiny slows down the deal process? Buyers might push back hard on these detailed accounting provisions. Lucas: It does add complexity, but it prevents the catastrophic misunderstandings that happen after closing. A few extra weeks of negotiation is preferable to losing millions in deferred compensation because of vague language. Luna: Speaking of negotiation, let us talk about the timeline. How long should these earnout periods realistically last? Lucas: The standard has drifted from one year to three or four years in sectors like biotech and SaaS. The problem with longer timelines is that they extend the founder’s exposure to integration risk. You are essentially working for free for several years after you have already exited. Luna: And if the buyer changes strategic direction entirely, those multi-year targets become irrelevant. There needs to be an acceleration clause for such scenarios. Lucas: That is a critical point. Acceleration clauses trigger if the buyer sells the division again or liquidates the assets. Without that protection, the seller is left holding the bag if the new owner decides to shutter the product line. Luna: I love that idea. It forces the buyer to consider the long-term implications of their restructuring decisions. Lucas: It aligns their interests somewhat. But we also need to address the staffing component. Often, the earnout requires the original management team to stay employed for the duration. Luna: That creates a hostage situation. If the culture clashes or the workload becomes unbearable, you cannot leave without forfeiting a massive chunk of your wealth. Lucas: Correct. Good contracts now include 'good leaver' provisions that allow departure without penalty due to health issues, termination without cause, or constructive dismissal. These safeguards are non-negotiable for experienced operators. Luna: It seems like the burden of proof is heavily skewed toward the buyer throughout the entire lifecycle of the deal. Lucas: Until recently, yes. But as more founders lose out on expected payouts, the market is correcting. Deal advisors are becoming much more aggressive in negotiating these protective terms from day one. Luna: What about the dispute resolution mechanism? Who decides when there is a disagreement about the calculated numbers? Lucas: This is usually handled by a neutral third-party accounting firm, often referred to as the arbiter. The key is ensuring that the arbiter has broad authority to interpret ambiguous terms, rather than just performing a mechanical calculation based on the buyer’s internal reports. Luna: So the contract must explicitly grant the arbiter discretion to override internal accounting policies if they conflict with the spirit of the agreement. Lucas: Exactly. And that brings us to a practical step for anyone considering an exit. Before you sign anything, you need to simulate the worst-case scenario. Model your earnout under restrictive accounting assumptions. Luna: Stress-testing the numbers against potential buyer actions is smart. It reveals the hidden vulnerabilities in the proposed structure. Lucas: It does. And if the numbers fall apart under stress testing, then the deal structure itself is flawed. You should not accept a valuation that relies on optimistic assumptions that the buyer can easily dismantle. Luna: That puts the responsibility squarely on the seller to understand the mechanics deeply. Passive reliance on the buyer’s word is no longer a viable strategy. Lucas: Agreed. The era of trusting the handshake is over. Every assumption must be written down, every metric defined, and every contingency planned for. Luna: I appreciate how you framed this as a structural issue rather than just bad faith. It highlights the importance of precise legal drafting in modern M&A. Lucas: It really does. And this segues into something important for our listeners who find value in these deep dives. If these conversations have moved your work forward in some small way, remember that listener support keeps this show running independently. Luna: A couple of dollars a month is genuinely what keeps these going, so check out buy me a coffee dot com slash fexingo if you want to help us keep producing this content. Lucas: Thank you for supporting independent analysis. Now, back to the technical side. Let us discuss the impact of customer churn on these earnout calculations. Luna: Churn is always tricky because it can spike immediately after a sale due to integration friction, which directly penalizes the seller's payout. Lucas: Right. Smart contracts now include a 'churn allowance' or a grace period where initial churn resulting from integration activities is excluded from the penalty calculations. Luna: That is a fair compromise. It acknowledges that some disruption is inevitable and shifts the focus to organic retention trends. Lucas: Exactly. It separates operational growing pains from fundamental product issues. This distinction protects the seller from penalties that are outside their control. Luna: It really comes down to fairness. Both parties should benefit from the synergy, but neither should be punished for factors they cannot influence. Lucas: Well said. As we wrap up, I want to leave you with one final thought. When evaluating any acquisition offer, look beyond the headline price. The true value is determined by the certainty of receipt. Luna: A guaranteed dollar today is worth infinitely more than a contingent promise tomorrow. Structure matters just as much as valuation. Lucas: Indeed. For anyone navigating a complex sale, take the time to scrutinize the fine print. Your future self will thank you for the diligence.